We have detected that the browser you are using is no longer supported. As a result, some content may not display correctly.
We suggest that you upgrade to the latest version of any of the following browsers:
close notification
Date
: 17/03/2006
Source: Department of Health
Title: Tshabalala-Msimang: National Conference on Health Research
Priority Setting
Speech by Minister of Health, Dr Manto Tshabalala-Msimang,
at the National Conference on Health Research Priority
Setting
Programme Director,
Representatives of the international organisations and donor
agencies,
Representatives from various departments of government,
Researchers,
Policy makers,
Members of the civil society including community advisory
boards,
Ladies and gentlemen,
It is with honour that I address this conference today and as you
know, health research is a vital part of our efforts to bring about
improved health status of our population.
This conference comes at a right time as we are involved in global
discussion on increasing access to HIV/AIDS prevention, treatment
and care. As we engage in this process of reviewing global progress
towards achieving the goals of the declaration of commitment on
HIV/AIDS the issue of research, monitoring and evaluation are
coming out as critical in assessing the success of our
interventions.
We need also to remember the discussion at the summit on health
research held in Mexico City, which looked at the role of research
in the attainment of the millennium development goals. The summit
once again highlighted the challenge of inadequate investment into
research on diseases that are the main contributors to the burden
of disease in the world. There is gross misallocation of research
funding with less than 10 percent of global health research
spending devoted to 90 percent of the global burden disease. While
the global burden of disease is overwhelmingly in developing
countries, investment for health research remains focused on
diseases affecting communities in highly industrialised
regions.
There have also been a meeting of African health Ministers in Abuja
to discuss issues of research in Africa. The Ministers recognised
the importance of research in improving health systems, the quality
of healthcare and healthy living as well as in providing evidence
based health policy formulation and implementation.
Ethics in health research have been of major concern over the past
decades, particularly regarding the vulnerability of research
participants. There is a long history of human rights abuse with
poor communities who have low levels of literacy and populations
with unquestioning acceptance of authority being the main
targets.
Programme Director, South Africa provides a unique environment for
research. The former advantaged areas of our country have good
infrastructure, skilled researchers and well equipped research
institutions comparable to many developed countries while the rest
of the population is affected the burden of diseases common to many
developing countries particularly in sub-Saharan Africa.
All these have attracted many international institutions to develop
and test their drugs in our country. As you know, increasing
research activity, competition and attractive research environment
may sometimes result in dishonest and fraudulent practice.
As we utilise the opportunities presented by this environment, we
need to ensure that we protect human rights particularly of
research participants as entrenched in our Constitution and the
National Health Act.
The National Health Act also provides for the establishment of the
National Health Research Ethics Council (NHREC). The Ethics Council
must:
* Register and audit health research ethics committees
* Set norms and standards for conducting research on humans and
animals, including norms and standards for conducting clinical
trials
* And adjudicate complaints and institute disciplinary action if
ethics have been contravened.
The establishment of the NHREC and committee is one of the most
important steps we have taken to ensure maintain ethical conduct in
research and protect the rights of research participants.
We have led the way in establishing government stewardship role in
setting priorities for research. The National Health Act has
dedicated a whole chapter on health research which, among others,
provides for the Minister to establish the National Health Research
Committee (NHRC).
The NHRC will advise the Minister on research priorities. In
identifying these priorities, the committee will take into
consideration the burden of disease, the cost effectiveness and
availability of human and institutional capacity for implementation
of interventions to address these diseases. The priority setting
should also take into consideration the health needs of vulnerable
groups including women and children, people with disabilities and
the elderly.
I am sure you will agree that this is indeed cutting edge
legislation. We will not only be focusing on the burden of disease,
but also addressing the needs of vulnerable groups and the needs of
communities.
Emergent diseases such as avian flu and Severe Acute Respiratory
Syndrome (SARS) have brought to the fore the reality that there are
no boundaries in the spread of diseases. At the same time, we are
faced with the challenge of other health conditions that are
neglected in terms of research such as tuberculosis, asthma,
hypertension and nutritional deficiencies, (including obesity and
malnutrition). All these call for renewed efforts on health
research focusing on these areas.
We also have deficiencies in the health systems which receive
little or no attention from donor organisation; international
organisation and local research institutions.
These areas include infection control in our health facilities,
integration of health information systems and improving efficiency
in the utilisation of resources available in the public and private
health sector. We therefore need to focus on research that improves
the functioning of the health system as a whole.
Programme Director, the rising cost of new drugs pose a major
public health burden and continue to limit the capacity of
Governments and people of Africa to access innovative and
appropriate drugs and other disease control tools.
Aside from the limitations of costs of medicines, challenges
encountered by many African countries also include limited
institutional capacity for forecasting need, procurement and
distribution and this is also applicable to South Africa.
Understanding that we are Africans with a particularly history
dating back several centuries, we need to also pay attention to
those things that sustained the health of Africans throughout our
history of denied access to health and other basic services.
We need to invest resources and efforts into the research and
development of African traditional medicine in particular which
have been suppressed through several years of colonialism and
apartheid.
No one will do this work for us. No one can reclaim our dignity on
our behalf. There is a great deal of literature on Indian or
Chinese traditional medicine. We need to establish those things
within African traditional medicine that add value to management of
diseases and improvement of health.
There are many health challenges before us. We need to be
broadminded in our approach and diversify our interventions. Our
success in the research and development of African traditional
medicine will probably be the best contribution the health sector
can make to the African renaissance.
In line with our endeavour to prioritise prevention of diseases, we
also have to focus on the area of behavioural science. We need to
establish the best measures we have to take to modify our own
behaviour or lifestyle that puts us at risk of contracting
communicable diseases like tuberculosis (TB) and AIDS and
developing non-communicable illnesses such as diabetes and
hypertension.
Programme Director, I am pleased to note that we have international
organisations and various collaborating partners here with us. The
substantive participation of donor agencies and international
institutions is critical in establishing a mutual understanding of
national priorities which should guide resource allocation.
I can also not stress enough the importance of developing capacity
within communities to be true partners in setting the research
agenda. Setting priorities without community participation would be
meaningless. I am therefore glad that members of the civil society
accepted our invitation and are part of this important process.
Also amongst us here are members from various Community Advisory
Boards on Research.
Priority setting should be a broad based, interactive, continuous
process that ensures equitable health development. Priority setting
should also have direct impact on funding decisions.
There are many competing social needs and resources available to
address these enormous challenges are limited. We therefore have to
find the best way to make maximum impact in improving the lives of
our people using the limited resources available. This requires
that we agree on our priorities as a country and focus our energies
and resources on those agreed upon areas.
I am looking forward to receiving the outcomes of this important
conference.